Dr TIM CARD's Outputs (2)

Erratum: Chest radiograph scoring alone or combined with other risk scores for predicting outcomes in covid-19: A UK study (2021)
Journal Article
Au-Yong, I., Higashi, Y., Giannotti, E., Fogarty, A., Morling, J. R., Grainge, M., Race, A., Juurlink, I., Simmonds, M., Briggs, S., Cruickshank, S., Hammond-Pears, S., West, J., Crooks, C. J., & Card, T. (2021). Erratum: Chest radiograph scoring alone or combined with other risk scores for predicting outcomes in covid-19: A UK study. Radiology, 301(3), E444. https://doi.org/10.1148/radiol.2021219021

Chest Radiograph Scoring Alone or Combined with Other Risk Scores for Predicting Outcomes in COVID- 19: A UK Study Iain Au-Yong, Yutaro Higashi, Elisabetta Giannotti, Andrew Fogarty, Joanne R. Morling, Matthew Grainge, Andrea Race, Irene Juurlink, Ma... Read More about Erratum: Chest radiograph scoring alone or combined with other risk scores for predicting outcomes in covid-19: A UK study.

Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation (2021)
Journal Article
Barberio, B., Savarino, E. V., Card, T., Canova, C., Baldisser, F., Gubbiotti, A., Massimi, D., Ghisa, M., & Zingone, F. (2022). Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation. Intestinal Research, 20(1), 114-123. https://doi.org/10.5217/ir.2021.00037

Background/Aims Current literature is lacking in studies comparing the incidence of adverse events (AEs) in patients with inflammatory bowel diseases (IBD) treated with adalimumab (ADA) or vedolizumab (VDZ) in a real-life scenario. Therefore, our pri... Read More about Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation.